Galactokinase deficiency: a treatable cause of bilateral cataracts

Catarina Cordeiro1, Paula Garcia2, Dalila Coelho2

  • 1Departamento Pediátrico - Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal ana_catarina_cordeiro@hotmail.com.

BMJ Case Reports
|June 5, 2021
PubMed

Insights

Galactokinase (GALK1) deficiency caused congenital cataracts in a 12-month-old girl. Genetic analysis identified a novel mutation, and dietary changes improved her condition.

Area of Science:

  • Ophthalmology
  • Medical Genetics
  • Biochemistry

Background:

  • Congenital cataracts necessitate differential diagnosis, considering infections, genetic, and metabolic disorders.
  • Early identification of underlying systemic diseases is crucial for managing congenital cataracts.

Observation:

  • A 12-month-old girl presented with bilateral nuclear cataracts without a family history or significant physical findings.
  • Systemic evaluation revealed biochemical evidence of abnormal galactose metabolism.

Findings:

  • The patient was diagnosed with galactokinase (GALK1) deficiency.
  • Genetic analysis identified a novel pathogenic missense mutation in the GALK1 gene.

Implications:

  • This case highlights GALK1 deficiency as a cause of congenital cataracts.
  • Prompt diagnosis and dietary management can lead to positive clinical outcomes in GALK1 deficiency.
  • Further research into GALK1 gene mutations and their clinical manifestations is warranted.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
430
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
7.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.4K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
906